Clinical Trial Update: Prevention of Developmental Delay and Xylitol (PDDaX) Study [NA]

View source ↗

Summary

A University of Washington-led clinical trial called PDDaX is evaluating whether xylitol can prevent developmental delay in preterm infants or those with neurod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurodevelopmental Disorders
• Preterm Birth

Drugs mentioned

• Xylitol (xylitol)

Snippet

Sponsor: University of Washington | Conditions: Prematurity, Neurodevelopmental Disorders | NA | Status: RECRUITING